|
Volumn 2, Issue 1, 2002, Pages 61-68
|
New targets for antipsychotics
a a |
Author keywords
Antipsychotics; Dopamine; NMDA; Pharmacogenetics; Receptors; Schizophrenia; Serotonin
|
Indexed keywords
ADROGOLIDE;
ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL;
AMISULPRIDE;
CLOZAPINE;
DEXTRO SERINE;
DOPAMINE 1 RECEPTOR;
DOPAMINE 2 RECEPTOR;
DOPAMINE 2 RECEPTOR BLOCKING AGENT;
DOPAMINE 3 RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
GLUTAMATE RECEPTOR AGONIST;
GLYCINE;
HALOPERIDOL;
MIANSERIN;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
RITANSERIN;
SEROTONIN 1A AGONIST;
SEROTONIN 1A RECEPTOR;
SEROTONIN 2A RECEPTOR;
SEROTONIN 2C ANTAGONIST;
SEROTONIN 2C RECEPTOR;
SEROTONIN 3 ANTAGONIST;
SEROTONIN 3 RECEPTOR;
AKATHISIA;
AMNESIA;
CATALEPSY;
DRUG ACTIVITY;
DRUG EFFICACY;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HYPERPROLACTINEMIA;
NEUROTOXICITY;
PHARMACOGENOMICS;
RECEPTOR AFFINITY;
RECEPTOR BLOCKING;
RECEPTOR DOWN REGULATION;
RECEPTOR OCCUPANCY;
REVIEW;
SCHIZOPHRENIA;
WORKING MEMORY;
|
EID: 0036283366
PISSN: 14737175
EISSN: None
Source Type: Journal
DOI: 10.1586/14737175.2.1.61 Document Type: Review |
Times cited : (9)
|
References (91)
|